Oligomerization of p53 Precedes its Association with Dynein and Nuclear Accumulation
暂无分享,去创建一个
[1] L. Grochow,et al. Phase I trial of taxol in patients with advanced cancer. , 1987, Cancer treatment reports.
[2] W. Deppert,et al. Redox factor 1 (Ref-1) enhances specific DNA binding of p53 by promoting p53 tetramerization , 2005, Oncogene.
[3] Dan L. Sackett,et al. p53 is associated with cellular microtubules and is transported to the nucleus by dynein , 2000, Nature Cell Biology.
[4] M. Christian,et al. Clinical development of Taxol. , 1993, Journal of the National Cancer Institute. Monographs.
[5] M. Clarke,et al. A Bipartite Nuclear Localization Signal Is Required for p53 Nuclear Import Regulated by a Carboxyl-terminal Domain* , 1999, The Journal of Biological Chemistry.
[6] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[7] T. Schroer,et al. Role for microtubules in centrosome doubling in Chinese hamster ovary cells. , 1999, Cell motility and the cytoskeleton.
[8] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[9] U. Kutay,et al. Transport between the cell nucleus and the cytoplasm. , 1999, Annual review of cell and developmental biology.
[10] M. Jordan,et al. Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.
[11] W. El-Deiry,et al. Regulation of p53 downstream genes. , 1998, Seminars in cancer biology.
[12] P. Chène,et al. The role of tetramerization in p53 function , 2001, Oncogene.
[13] C. Arrowsmith,et al. Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor. , 1995, Biochemistry.
[14] E. Stavridi,et al. Hydrophobic side‐chain size is a determinant of the three‐dimensional structure of the p53 oligomerization domain , 1997, The EMBO journal.
[15] M. Clarke,et al. Cooperation of a Single Lysine Mutation and a C-terminal Domain in the Cytoplasmic Sequestration of the p53 Protein* , 1998, The Journal of Biological Chemistry.
[16] M. Remm,et al. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization. , 1992, Oncogene.
[17] M. Sheng,et al. The 8-kDa Dynein Light Chain Binds to p53-binding Protein 1 and Mediates DNA Damage-induced p53 Nuclear Accumulation* , 2005, Journal of Biological Chemistry.
[18] K. Downing,et al. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. , 2000, Annual review of cell and developmental biology.
[19] M. Oren,et al. mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.
[20] G. Wahl,et al. A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking , 1999, The EMBO journal.
[21] R. Ribeiro,et al. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer , 2002, Nature Structural Biology.
[22] E. Nogales,et al. Tubulin structure: insights into microtubule properties and functions. , 1998, Current opinion in structural biology.
[23] M. Ljungman,et al. Hsp90-binding Immunophilins Link p53 to Dynein During p53 Transport to the Nucleus* , 2004, Journal of Biological Chemistry.
[24] J N Weinstein,et al. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. , 1997, Cancer research.
[25] E. Rowinsky. Paclitaxel pharmacology and other tumor types. , 1997, Seminars in oncology.
[26] C. Harris,et al. p53: traffic cop at the crossroads of DNA repair and recombination , 2005, Nature Reviews Molecular Cell Biology.
[27] A. Fersht,et al. Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain , 1998, The EMBO journal.
[28] H. Joshi. Microtubule dynamics in living cells. , 1998, Current opinion in cell biology.
[29] P. Friedman,et al. The p53 protein is an unusually shaped tetramer that binds directly to DNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] N. Hirokawa,et al. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. , 1998, Science.
[31] E. Appella,et al. Signaling to p53: breaking the posttranslational modification code. , 2000, Pathologie-biologie.
[32] D. Lane,et al. The p53 tumour suppressor gene , 1998, The British journal of surgery.
[33] V. Rotter,et al. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis , 1990, Molecular and cellular biology.
[34] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[35] D. DeFranco,et al. Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement. , 2004, Cellular signalling.
[36] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.
[37] T. Curran,et al. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[38] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[39] H. Goodson,et al. Motors and membrane traffic. , 1997, Current opinion in cell biology.
[40] M. Jordan,et al. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. , 1998, Current opinion in cell biology.